ArticleFrontiers in oncology2022

S-1 Maintenance Therapy After First-Line Treatment With Nab-Paclitaxel Plus S-1 for Advanced Pancreatic Adenocarcinoma: A Real-World Study.

Yan Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.